ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $10,994,000 | -29.7% | 269,876 | +6.5% | 0.07% | -9.0% |
Q4 2019 | $15,631,000 | -15.4% | 253,473 | 0.0% | 0.08% | -23.5% |
Q3 2019 | $18,473,000 | -23.8% | 253,473 | -14.0% | 0.10% | -24.4% |
Q2 2019 | $24,236,000 | +43.1% | 294,852 | +22.8% | 0.14% | +37.8% |
Q1 2019 | $16,941,000 | +60.1% | 240,166 | +2.2% | 0.10% | +48.5% |
Q4 2018 | $10,579,000 | -13.3% | 234,995 | +8.9% | 0.07% | +1.5% |
Q3 2018 | $12,195,000 | +25.3% | 215,695 | +48.0% | 0.06% | +16.1% |
Q2 2018 | $9,732,000 | +14.7% | 145,695 | 0.0% | 0.06% | +16.7% |
Q1 2018 | $8,482,000 | -9.7% | 145,695 | 0.0% | 0.05% | -5.9% |
Q4 2017 | $9,390,000 | -52.1% | 145,695 | -61.0% | 0.05% | -54.5% |
Q3 2017 | $19,610,000 | +11.3% | 373,595 | -0.7% | 0.11% | +8.7% |
Q2 2017 | $17,615,000 | +27.9% | 376,395 | +35.3% | 0.10% | +25.6% |
Q1 2017 | $13,768,000 | +97.7% | 278,095 | +80.2% | 0.08% | +90.7% |
Q4 2015 | $6,964,000 | +30178.3% | 154,336 | +25622.7% | 0.04% | – |
Q3 2015 | $23,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |